Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated.

Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated. Oncology (Williston Park). 2019 Jul 15;33(7): Authors: Saleh N, Copur MS PMID: 31365755 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31365755?dopt=Abstract

Source: Oncology (Williston Park, N.Y.) - July 14, 2019 Category: Cancer & Oncology Authors: Saleh N, Copur MS Tags: Oncology (Williston Park) Source Type: research

More News: Cancer & Oncology